16:0-d31-18:1 PA
Manufacturer: Sigma Aldrich
CAS Number: 474943-59-4
Synonym(S): 110920
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 MG | 860453C-10-MG | In Stock | ₹ 30,461.55 |
860453C - 10 MG
In Stock
Quantity
1
Base Price: ₹ 30,461.55
GST (18%): ₹ 5,483.079
Total Price: ₹ 35,944.629
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (860453C-10mg)
manufacturer/tradename
Avanti Polar Lipids 860453C
concentration
10 mg/mL (860453C-10mg)
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP(O)([O-])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H]
InChI
1S/C37H71O8P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,35H,3-16,19-34H2,1-2H3,(H2,40,41,42);/q;+1/p-1/b18-17-;/t35-;/m1./s1/i2D3,4D2,6D2,8D2,10D2,12D2,14D2,16D2,19D2,21D2,23D2,25D2,27D2,29D2,31D2;
InChI key
PPYXMAJBOKWTQX-VYSSPCEXSA-M
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 474943-59-4 | 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (sodium salt) | A2B Chem | ₹ 1,05,581.04 |
Related Products
Description
- General description: Deuterated fatty acids experience exchange of the deuteriums on the alpha carbon to the carbonyl, i.e., C2 position, and will therefore be a mixture of compounds that are fully deuterated and partially deuterated at that position.
- Application: 16:0-d31-18:1 PA has been used as an internal standard to quantify fatty acid methyl esters (FAMES) using electrospray ionization tandem mass spectrometry (ESI-MS/MS)-based lipidomic analysis.[1]
- Packaging: 5 mL Clear Glass Sealed Ampule (860453C-10mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (860453C-10mg)
manufacturer/tradename: Avanti Polar Lipids 860453C
concentration: 10 mg/mL (860453C-10mg)
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP(O)([O-])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H]
InChI: 1S/C37H71O8P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(39)45-35(34-44-46(40,41)42)33-43-36(38)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,35H,3-16,19-34H2,1-2H3,(H2,40,41,42);/q;+1/p-1/b18-17-;/t35-;/m1./s1/i2D3,4D2,6D2,8D2,10D2,12D2,14D2,16D2,19D2,21D2,23D2,25D2,27D2,29D2,31D2;
InChI key: PPYXMAJBOKWTQX-VYSSPCEXSA-M
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (860455P-1mg)pkg of 1 × 5 mg (860455P-5mg)
manufacturer/tradename: Avanti Polar Lipids 860455P
concentration: __
shipped in: dry ice
storage temp.: −20°C
SMILES string: __
InChI: __
InChI key: __
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (860456P-1mg)
manufacturer/tradename: Avanti Polar Lipids 860456P
concentration: __
shipped in: dry ice
storage temp.: −20°C
SMILES string: __
InChI: __
InChI key: __
